BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, today announces an agreement with Novo Nordisk, a world leader in diabetes care, for the development and distribution (pending successful development) of a Mallya smart add-on device for the Novo Nordisk FlexTouch pen used by people with diabetes.

Information for unitholders of the QUADRIGE FRANCE Smallcaps and QUADRIGE RENDEMENT France Midcaps funds
The Management Company informs unitholders of the QUADRIGE
